The impact of DRGs on the cost and quality of health care in the United States

Medicine & Life Sciences

• Prospective Payment System 100%
• Diagnosis-Related Groups 77%
• Quality of Health Care 58%
• Costs and Cost Analysis 41%
• Medicare 30%
• Inpatients 23%
• Product Line Management 16%
• Incentive Reimbursement 10%
• State Government 10%
• Health Maintenance Organizations 9%
• Financial Management 8%
• Health Insurance 7%
• Growth 7%
• Motivation 6%
• Length of Stay 5%
• Outpatients 5%
• Elderly 5%
• Delivery of Health Care 4%
• Mortality 3%

Social Sciences

• Quality of Health Care 95%
• costs 37%
• inpatient care 16%
• inpatient hospital 9%
• incentive 8%
• insolvency 7%
• Trust funds 7%
• medical services 6%
• Quality of care 6%
• insurance 5%
• mortality 4%
• utilization 4%
• health care 4%
• efficiency 3%
• Group 3%
• management 2%
• resources 2%